Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis - A case report

Lung Cancer

Volumn 40, Issue 1, 2003, Pages 99-101

  Chen, Yuh Min ^a   Chen, Mei Chun ^a   Tsai, Chun Ming ^a   Perng, Reury Perng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cancer; Carcinomatosis; Structure

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEMCITABINE; IFOSFAMIDE;

ADULT; ARTICLE; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL FEATURE; DEATH; DIAGNOSTIC PROCEDURE; FATIGUE; FOLLOW UP; HEADACHE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037377664     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00504-4     Document Type: Article

References (9)

1. DeAngelis L.M. Current diagnosis and treatment of leptomeningeal metastasis. J. Neurooncol. 38:1998;245-252.
2. Esteva F.J., Soh L.T., Holmes F.A., et al. Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer. Cancer Chemother. Pharmacol. 46:2000;382-386.
3. Jaeckle K.A., Phuphanich S., Bent M.J., et al. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br. J. Cancer. 84:2001;157-163.
4. De Angelis L.M. Diagnosis and treatment of leptomeningeal metastasis. ASCO. 3:2002;369-374.
5. Chamberlain M.C. New approaches to current treatment of leptomeningeal metastases. Curr. Opin. Neurol. 7:1994;492-500.
6. Wasserstrom W.R., Glass J.P., Posner J.B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 49:1982;759-772.
7. Balm M., Hammack J. Leptomeningeal carcinomatosis - presenting features and prognostic factors. Arch. Neurol. 53:1996;626-632.
8. Sandberg D.I., Bilsky M.H., Souweidane M.M., et al. Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery. 47:2000;49-55.
9. Sandler A.B., Nemunaitis J., Denham C., et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J. Clin. Oncol. 18:2000;122-130.